Insider Trading Alert - PFNX, CAC And USAP Traded By Insiders

Yesterday, Nov. 5, 2015, 68 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $5.04 to $15,303,456.72.

Highlighted Stocks Traded by Insiders:

Pfenex (PFNX) - FREE Research Report

Lucy Patrick K., who is Chief Business Officer at Pfenex, sold 1,500 shares at $17.54 on Nov. 5, 2015. Following this transaction, the Chief Business Officer owned 107,190 shares meaning that the stake was reduced by 1.38% with the 1,500-share transaction.

The shares most recently traded at $16.32, down $1.22, or 7.46% since the insider transaction. Historical insider transactions for Pfenex go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 18,000
  • 24-Week # shares sold: 37,500

The average volume for Pfenex has been 102,300 shares per day over the past 30 days. Pfenex has a market cap of $401.2 million and is part of the health care sector and drugs industry. Shares are up 133.43% year-to-date as of the close of trading on Thursday.

Pfenex Inc., a clinical-stage biotechnology company, develops biosimilar therapeutics. Its lead product candidate is PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in patients with wet age-related macular degeneration. The company has a P/E ratio of 12.8. Currently, there are 2 analysts who rate Pfenex a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PFNX - FREE

TheStreet Quant Ratings rates Pfenex as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income. Get the full Pfenex Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Camden National (CAC) - FREE Research Report

Hayden Edmund M, who is Evp at Camden National, sold 6,076 shares at $40.76 on Nov. 5, 2015. Following this transaction, the Evp owned 0 shares meaning that the stake was reduced by 100% with the 6,076-share transaction.

The shares most recently traded at $43.45, up $2.69, or 6.19% since the insider transaction. Historical insider transactions for Camden National go as follows:

  • 4-Week # shares bought: 1,080
  • 4-Week # shares sold: 505
  • 12-Week # shares bought: 1,580
  • 12-Week # shares sold: 505
  • 24-Week # shares bought: 2,860
  • 24-Week # shares sold: 505

The average volume for Camden National has been 18,000 shares per day over the past 30 days. Camden National has a market cap of $315.3 million and is part of the financial sector and banking industry. Shares are up 7.48% year-to-date as of the close of trading on Thursday.

Camden National Corporation operates as the holding company for Camden National Bank that provides commercial and consumer banking products and services to consumer, institutional, municipal, non-profit, and commercial customers primarily in Maine. The stock currently has a dividend yield of 2.84%. The company has a P/E ratio of 12.5. Currently, there are 2 analysts who rate Camden National a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAC - FREE

TheStreet Quant Ratings rates Camden National as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in net income and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Camden National Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Universal Stainless & Alloy Products (USAP) - FREE Research Report

Zimmer Christopher M, who is Exec. VP & Chief Commercial Of at Universal Stainless & Alloy Products, bought 3,000 shares at $11.00 on Nov. 5, 2015. Following this transaction, the Exec. VP & Chief Commercial Of owned 10,800 shares meaning that the stake was boosted by 38.46% with the 3,000-share transaction.

The shares most recently traded at $11.23, up $0.23, or 2.05% since the insider transaction. Historical insider transactions for Universal Stainless & Alloy Products go as follows:

  • 4-Week # shares bought: 8,400
  • 12-Week # shares bought: 8,400
  • 24-Week # shares bought: 13,900

The average volume for Universal Stainless & Alloy Products has been 55,800 shares per day over the past 30 days. Universal Stainless & Alloy Products has a market cap of $82.0 million and is part of the basic materials sector and metals & mining industry. Shares are down 54.12% year-to-date as of the close of trading on Thursday.

Universal Stainless & Alloy Products, Inc., and its subsidiaries manufacture and market semi-finished and finished specialty steel products in the United States and internationally. The company's products include stainless steel, nickel alloys, tool steel, and various other alloyed steels. Currently, there are no analysts who rate Universal Stainless & Alloy Products a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on USAP - FREE

TheStreet Quant Ratings rates Universal Stainless & Alloy Products as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Universal Stainless & Alloy Products Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow Falls Sharply as Weak China Data Worries Wall Street

Dow Falls Sharply as Weak China Data Worries Wall Street

Walgreens Slides on Downgrade From Goldman Sachs

Walgreens Slides on Downgrade From Goldman Sachs

Adobe Takes Hit as Acquisition Costs Muddy Results and Outlook

Adobe Takes Hit as Acquisition Costs Muddy Results and Outlook

FOMC - The Gang That Couldn't Shoot Straight: Market Recon

FOMC - The Gang That Couldn't Shoot Straight: Market Recon

What Drives Commodity Volatility?

What Drives Commodity Volatility?